Clinical Trial Update: Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the safety and immunogenicity of a human hookworm vaccine in Brazilian adults, with and without an additional adjuvant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hookworm Disease
• Hookworm Infection

Drugs mentioned

• Human Hookworm Candidate Vaccine

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hookworm Infection, Hookworm Disease | Phase 1 | Status: COMPLETED